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The emergence of carbapenem-resistant Gram-negative pathogens poses a
serious threat to public health worldwide. In particular, the increasing prevalence
of carbapenem-resistant Klebsiella pneumoniae is a major source of concern.
K. pneumoniae carbapenemases (KPCs) and carbapenemases of the oxacillinase-
48 (OXA-48) type have been reported worldwide. New Delhi metallo-β-lactamase
(NDM) carbapenemases were originally identified in Sweden in 2008 and have spread
worldwide rapidly. In this review, we summarize the epidemiology of K. pneumoniae
producing three carbapenemases (KPCs, NDMs, and OXA-48-like). Although the
prevalence of each resistant strain varies geographically, K. pneumoniae producing
KPCs, NDMs, and OXA-48-like carbapenemases have become rapidly disseminated.
In addition, we used recently published molecular and genetic studies to analyze the
mechanisms by which these three carbapenemases, and major K. pneumoniae clones,
such as ST258 and ST11, have become globally prevalent. Because carbapenemase-
producing K. pneumoniae are often resistant to most β-lactam antibiotics and many
other non-β-lactam molecules, the therapeutic options available to treat infection
with these strains are limited to colistin, polymyxin B, fosfomycin, tigecycline, and
selected aminoglycosides. Although, combination therapy has been recommended
for the treatment of severe carbapenemase-producing K. pneumoniae infections, the
clinical evidence for this strategy is currently limited, and more accurate randomized
controlled trials will be required to establish the most effective treatment regimen.
Moreover, because rapid and accurate identification of the carbapenemase type found
in K. pneumoniae may be difficult to achieve through phenotypic antibiotic susceptibility
tests, novel molecular detection techniques are currently being developed.
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INTRODUCTION
The increasing prevalence of antibiotic resistance and the lack
of new antibiotic drug development has gradually reduced the
treatment options for bacterial infections (Lee et al., 2013a;
Nathan and Cars, 2014). In 2013, the Centers for Disease
Control and Prevention (CDC) named three microorganisms
that pose an urgent threat to public health: carbapenem-
resistant (CR) Enterobacteriaceae (CRE), drug-resistant Neisseria
gonorrhoeae, and Clostridium difficile (Zowawi et al., 2015).
Carbapenems (imipenem, meropenem, biapenem, ertapenem,
and doripenem) are antibiotics used for the treatment of severe
infections caused by multi-resistant Enterobacteriaceae, such as
Klebsiella pneumoniae and Escherichia coli (Nordmann et al.,
2009). However, over the past 10 years, CRE have increasingly
been reported worldwide (Nordmann et al., 2011a). In particular,
K. pneumoniae have acquired carbapenemases, which are
enzymes capable of breaking down most β-lactams including
carbapenems, and thus conferring resistance to these drugs (Jeon
et al., 2015). High mortality rates have been reported in patients
with bloodstream infections caused by CR K. pneumoniae
(Munoz-Price et al., 2013). Carbapenemases can be divided
according to their dependency on divalent cations for enzyme
activation into metallo-carbapenemases (zinc-dependent class
B) and non-metallo-carbapenemases (zinc-independent classes
A, C, and D; Jeon et al., 2015). The class A carbapenemases,
such as the K. pneumoniae carbapenemase (KPC) enzymes,
have been identified worldwide in K. pneumoniae (Tangden
and Giske, 2015). Various class B and D carbapenemases
have also been detected in hospital-acquired multi-resistant
K. pneumoniae (Nordmann et al., 2011a), whereas class C
carbapenemases have rarely been reported. In this review,
we summarize the epidemiology of the major four classes of
carbapenemases and discuss their molecular genetics, methods
used for their detection, and the therapeutic options available for
their treatment.
THE EPIDEMIOLOGY, GENETIC






Various class A carbapenemases forming six distantly related
branches have been identified (Jeon et al., 2015). While some
carbapenemases are chromosome-encoded (IMI-1, NMC-A,
SME enzymes, SHV-38, and SFC-1), others are plasmid-encoded
(KPC enzymes, GES enzymes, and IMI-2). KPCs have been the
most frequently observed class A carbapenemases since their first
description in the eastern the USA in 1996 (Yigit et al., 2001). Of
the many different KPC family variants (KPC-1 to KPC-22), the
most well-characterized variants are KPC-2 and KPC-3. KPCs are
mostly plasmid-encoded enzymes and bacteria producing these
enzymes are susceptible to only a few antibiotics such as colistin,
aminoglycosides, and tigecycline. Therefore, the mortality of the
patient’s bloodstream infections caused by these bacteria is very
high (Munoz-Price et al., 2013).
The epidemiology of K. pneumoniae producing KPCs varies
geographically. The endemic spread of these bacteria has been
reported in the USA, China, Italy, Poland, Greece, Israel, Brazil,
Argentina, Colombia, and Taiwan (Munoz-Price et al., 2013;
Figure 1). Sporadic spread of KPC-producing K. pneumoniae has
also been observed in many European countries including Spain,
France, Germany, the Netherlands, the UK, Ireland, Belgium,
Sweden, and Finland, and in several countries in the Asia-Pacific
region, including India, South Korea, and Australia (Munoz-
Price et al., 2013; Nordmann and Poirel, 2014). In the USA,
the transmission of CR K. pneumoniae is primarily driven by
the spread of organisms carrying KPC enzymes (Kaiser et al.,
2013), but other carbapenemase enzymes, such as the New-Delhi
metallo-β-lactamase (NDM), have also emerged (Lascols et al.,
2013). Within the USA, the prevalence of KPC-positive isolates
was relatively stable between 2007 and 2009 (5.9% in 2007, 4.9%
in 2008, and 5.7% in 2009; Kaiser et al., 2013), and KPC-2 and
KPC-3 were the most frequently identified carbapenemases in
K. pneumoniae (Deshpande et al., 2006).
The outbreaks caused by KPC-producing K. pneumoniae
have been reported in the USA (Woodford et al., 2004) and
Israel (Leavitt et al., 2007), but recently, similar outbreaks
associated with patients traveling to endemic areas have also
been reported in many European counties. Since KPC-producing
K. pneumoniae was identified in France, Italy, and Greece (Naas
et al., 2005; Tsakris et al., 2008; Giani et al., 2009), the sporadic
spread of KPC-producing K. pneumoniae has been observed in
many European countries including Spain (Robustillo Rodela
et al., 2012), France (Carbonne et al., 2010), Germany (Wendt
et al., 2010; Steinmann et al., 2011), the Netherlands (Weterings
et al., 2015), the UK (Woodford et al., 2008; Virgincar et al.,
2011), Ireland (Roche et al., 2009; Morris et al., 2012), Belgium
(Bogaerts et al., 2010), Sweden (Samuelsen et al., 2009), and
Finland (Osterblad et al., 2012; Kanerva et al., 2015). KPC-
producing K. pneumoniae were also recently detected in eastern
European countries including the Czech Republic (Hrabak et al.,
2013b), Hungary (Toth et al., 2010), and Croatia (Bedenic et al.,
2012).
In Greece, KPC-producing K. pneumoniae was first isolated in
August 2007 (Tsakris et al., 2008), and the prevalence of KPC-
producers among carbapenemase-producing K. pneumoniae
isolates collected at a tertiary Greek hospital increased from 0%
in 2003 to 38.3% in 2010 (Zagorianou et al., 2012). Most of the
genotyped KPC-producing K. pneumoniae in Greece harbored
KPC-2 (Zagorianou et al., 2012). While many carbapenemase-
producing K. pneumoniae in the USA and Greece had KPC
enzymes (Nordmann et al., 2009; Zagorianou et al., 2012), several
studies in Spain showed that most carbapenemase-producing
K. pneumoniae harbored OXA-48-like or class B carbapenemases,
and the rate of KPC- producing K. pneumoniae was very low
(2–3%; Oteo et al., 2013b; Palacios-Baena et al., 2016). These
results indicate that the prevalent genotype of carbapenemase-
producing K. pneumoniae varies geographically. For example, in
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FIGURE 1 | Epidemiological features of KPC-producing Klebsiella pneumoniae. (1) USA; (2) Colombia; (3) Brazil; (4) Argentina; (5) Italy; (6) Greece; (7)
Poland; (8) Israel; (9) China; (10) Taiwan; (11) Canada; (12) Spain; (13) France; (14) Belgium; (15) Netherlands; (16) Germany; (17) UK; (18) Ireland; (19) Sweden; (20)
Finland; (21) Hungary; (22) India; (23) South Korea; (24) Australia; (25) Mexico; (26) Cuba; (27) Puerto Rico; (28) Uruguay; (29) Portugal; (30) Switzerland; (31) Austria;
(32) Czech Republic; (33) Denmark; (34) Norway; (35) Croatia; (36) Turkey; (37) Algeria; (38) Egypt; (39) South Africa; (40) Iran; (41) United Arab Emirates; (42)
Pakistan; (43) Russia; (44) Japan.
Italy which is a representative southern European country where
KPC is becoming endemic, 89.5% of carbapenemase producers
have been reported to have KPC-type enzymes, followed by
VIM-1 (9.2%) and OXA-48 (1.3%; Giani et al., 2013).
In America, the endemic spread of KPCs has been reported in
Colombia (Villegas et al., 2006; Rojas et al., 2013), Brazil (Peirano
et al., 2009; Fehlberg et al., 2012), and Argentina (Pasteran
et al., 2008; Gomez et al., 2011). In Canada, KPC-producing
K. pneumoniae has sporadically been reported (Goldfarb et al.,
2009; Lefebvre et al., 2015), and since plasmid-mediated KPC-
producing K. pneumoniae was first detected in Ottawa in
Goldfarb et al. (2009), a laboratory surveillance program
found a high frequency (89.3%) of KPC-type enzymes among
carbapenemase producers between 2010 and 2012 (Lefebvre et al.,
2015). The emergence of KPCs in Argentina was characterized
by two patterns of dispersion: the first was the irregular
occurrence of diverse Enterobacteriaceae harboring blaKPC−2
in the IncL/M transferable plasmid in distant regions and the
second was the sudden clonal spread of K. pneumoniae ST258
harboring blaKPC−2 in Tn4401a (Gomez et al., 2011). KPC-
producing K. pneumoniae was recently also detected in Cuba
(Quinones et al., 2014), Mexico (Garza-Ramos et al., 2014),
Uruguay (Marquez et al., 2014), and Puerto Rico (Gregory et al.,
2010).
In the Asia-Pacific region, the endemic dissemination of
KPC-producing K. pneumoniae has been reported in China (Li
et al., 2014) and Taiwan (Tseng et al., 2015), and the sporadic
spread has been reported in India (Shanmugam et al., 2013),
South Korea (Yoo et al., 2013), and Australia (Partridge et al.,
2015). A novel KPC-15 variant which is closely homologous
with KPC-4 was discovered in China (Wang et al., 2014b) and
its enzymatic activity and phenotype was characterized (Wang
et al., 2014a). In China, the frequency of KPC-type enzymes
among carbapenemase producers was high (63%; Li et al., 2014).
While ST258 is the predominant clone observed in European
countries and the USA (Giani et al., 2013; Chen et al., 2014e;
Bowers et al., 2015), ST11, which is closely related to ST258,
is the prevalent clone associated with the spread of KPC-
producing K. pneumoniae in Asia (particularly in China and
Taiwan; Qi et al., 2011; Yang et al., 2013; Tseng et al., 2015). KPC-
producing ST11 strain has also been reported in Latin America
(Munoz-Price et al., 2013). Although it is unknown why ST11
is prevalent, a recent report showed that the KPC-producing
K. pneumoniae ST11 clone was resistant to serum killing (Chiang
et al., 2016). In a Chinese hospital, another nosocomial outbreak
of KPC-2-producing K. pneumoniae was caused by multiple
K. pneumoniae strains including ST37, ST392, ST395, and ST11,
implying the horizontal transfer of blaKPC−2 gene between
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different K. pneumoniae clones in China (Yang et al., 2013). In
Taiwan, two novel KPC variants were identified; KPC-16 and
KPC-17 differed from KPC-2 by two (P202S and F207L) and a
single (F207L) amino acid substitutions, respectively (Yu et al.,
2015). A nationwide survey in Taiwan between 2011 and 2013
reported the national spread of KPC-2 and KPC-17 (Tseng et al.,
2015). KPC-producing K. pneumoniae was recently also detected
in Japan (Saito et al., 2014), Pakistan (Pesesky et al., 2015), Iran
(Nobari et al., 2014), and United Arab Emirates (Sonnevend
et al., 2015a). In the Arabian Peninsula, the prevalence of
KPC-producing K. pneumoniae was very low in comparison to
NDM-1 and OXA-48-like carbapenemases (Sonnevend et al.,
2015b). Sonnevend et al. (2015a), two K. pneumoniae ST14
strains producing KPC-2 were first identified in the United Arab
Emirates of the Arabian Peninsula. In Africa, several countries
such as South Africa (Brink et al., 2012), Algeria (Bakour et al.,
2015b), and Egypt (Metwally et al., 2013), have also isolated
KPC-producing K. pneumoniae.
The coexistence of KPCs and other carbapenemases in
K. pneumoniae was frequently reported worldwide, including
in Italy (KPC-3/VIM-2 and KPC-2/VIM-1; Richter et al., 2012;
Perilli et al., 2013), Colombia (KPC-2/VIM-24; Rojas et al.,
2013), Brazil (KPC-2/NDM-1; Pereira et al., 2015), China (KPC-
2/NDM-1, KPC-2/CMY-2, and KPC-2/IMP-4; Hu et al., 2014;
Dong et al., 2015; Liu et al., 2015), Canada (KPC-3/CMY-2;
Leung et al., 2012), and Greece (KPC-2/VIM-1; Giakkoupi et al.,
2009), indicating the worldwide prevalence of K. pneumoniae
co-harboring two carbapenemases.
Aside from KPC-type carbapenemases, other class A
carbapenemases, such as GES-2, GES-4, GES-5, GES-6, GES-11,
GES-14, GES-18, SFC-1, SHV-38, NMC-A, SME-1, and IMI-type
enzymes, were rarely found in K. pneumoniae (Table 1).
Molecular and Genetic Context
The blaKPC in K. pneumoniae has been reported on numerous
plasmid types, such as IncF, IncI2, IncX, IncA/C, IncR, and
ColE1 (Garcia-Fernandez et al., 2012; Chen et al., 2014e;
Pitout et al., 2015), but the predominant plasmid type is IncF
with FIIK replicons (Pitout et al., 2015). IncF often contains
several additional genes responsible for resistance to other
antibiotics, including aminoglycosides, tetracyclines, quinolones,
trimethoprim, and sulfonamides (Pitout et al., 2015). Many
blaKPC genes are associated with a promiscuous transposon-
related structure Tn4401, which is approximately 10 kb in
size and consists of a transposase gene, a resolvase gene, the
blaKPC gene, and two insertion sequences, ISKpn6 and ISKpn7
(Figure 2A; Naas et al., 2008). This transposon has jumped to
numerous plasmids that are commonly conjugative (Chen et al.,
2014e). In China, a novel genetic environment was detected (Shen
et al., 2009). It contains an integration structure consisting of
a Tn3-based transposon and partial Tn4401 segment, with the
gene order Tn3-transposase, Tn3-resolvase, ISKpn8, the blaKPC−2
TABLE 1 | The epidemiology of various carbapenemases in Klebsiella pneumoniae.
Molecular class Carbapenemase Geographical distribution
A SME types Not found
IMI types Not found
GES types Greece (Vourli et al., 2004), Finland (Osterblad et al., 2012), Brazil (Picao et al.,
2010), and South Korea (Jeong et al., 2005; Bae et al., 2007)
SFC-1, SHV-38, and NMC-A France (Poirel et al., 2003) and Brazil (Tollentino et al., 2011)





C DHA-1 Taiwan (Lee et al., 2012b), South Korea (Park et al., 2013), and China (Hu et al.,
2014)
CMY-2 and CMY-10 China (Hu et al., 2014), Canada (Leung et al., 2012), and Greece (Pournaras
et al., 2010b)
ADC-68 Not found
D IMP types Malaysia (Hamzan et al., 2015), Taiwan (Tseng et al., 2015), China (Chen et al.,
2015), Thailand (Rimrang et al., 2012), Ireland (Morris et al., 2016), Greece
(Lascols et al., 2013), Spain (Lascols et al., 2013), Italy (Lascols et al., 2013),
Turkey (Lascols et al., 2013), Austria (Zarfel et al., 2011), the USA (Limbago
et al., 2011; Rojas et al., 2013), and Mexico (Gales et al., 2012)
VIM types Greece (Pournaras et al., 2010b), Ireland (Morris et al., 2016), Spain (Pena
et al., 2014), Australia (Lascols et al., 2013), Croatia (Zujic Atalic et al., 2014),
the Czech Republic (Hrabak et al., 2013b), Hungary (Melegh et al., 2014), Italy
(Giani et al., 2013), Norway (Naseer et al., 2012), Austria (Zarfel et al., 2011),
Finland (Osterblad et al., 2012), Germany (Steinmann et al., 2011), France
(Birgy et al., 2011), China (Liu et al., 2015), India (Castanheira et al., 2011),
Philippines (Lascols et al., 2013), Iran (Rajabnia et al., 2015), Taiwan (Tseng
et al., 2015), Colombia (Rojas et al., 2013), Mexico (Gales et al., 2012), and
Algeria (Rodriguez-Martinez et al., 2010)
GIM-1, KHM-1, and SPM-1 Not found
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FIGURE 2 | Structural features of representative genetic environments of blaKPC−2, blaNDM−1, and blaOXA−48 genes. (A) The blaKPC−2-containing Tn4401
transposon from the plasmid pNYC (GenBank accession no. EU176011) is shown in horizontal arrows. Two inverted repeat sequences (IRL and IRR) of Tn4401 are
depicted in triangles at either end. Tn4401 has five isoforms which differ by deletions (68–255 bp) just upstream of the blaKPC gene [(a) deletion of 99 bp; (b) no
deletion; (c) deletion of 215 bp; (d) deletion of 68 bp; (e) deletion of 255 bp]. (B) The blaNDM−1 genetic context of pNDM_MGR194 (GenBank accession no.
KF220657) is shown in horizontal arrows. (C) The blaOXA−48-containing Tn1999 transposon from the plasmid pOXA-48 (GenBank accession no. JN626286) is
shown in horizontal arrows.
gene, and the ISKpn6-like element (Shen et al., 2009). This
genetic structure is the chimera form of several transposon-
associated elements. This transposon was also identified in many
other countries (Chen et al., 2014e), and several variants with
various fragment insertions between the ISKpn8 and blaKPC
gene have been found among Enterobacteriaceae in China
(Shen et al., 2009; Li et al., 2011; Qi et al., 2011). Tn4401
has five isoforms which differ by deletions (68–255 bp) just
upstream of the blaKPC gene [(a) deletion of 99 bp; (b) no
deletion; (c) deletion of 215 bp; (d) deletion of 68 bp; (e)
deletion of 255 bp; Chen et al., 2014e]. Notably, in many
cases, different Tn4401 isoforms was associated with different
blaKPC-harboring plasmids. Tn4401a was frequently found in
the blaKPC−3-harboring IncFIIK2 plasmids (Leavitt et al., 2010;
Garcia-Fernandez et al., 2012; Chen et al., 2014d), and Tn4401b
and Tn4401d were often associated with the IncN and IncFIA
plasmids, respectively (Chen et al., 2013a, 2014c,e). Up to
now, more than 30 blaKPC-harboring plasmids obtained from
K. pneumoniae have been sequenced (Gootz et al., 2009; Shen
et al., 2009; Jiang et al., 2010; Leavitt et al., 2010; Almeida
et al., 2012; Chen et al., 2013a,b, 2014b,c,e). One of common
features shared by these sequenced plasmids is the presence of the
tra operon, which encodes the plasmid conjugation machinery
proteins that induce the spread of plasmids (Chen et al., 2014e).
These genes may be important for the successful dissemination
of blaKPC-harboring plasmids. The IncFII plasmids are one of
predominant blaKPC-harboring plasmids. pKpQIL, which is an
IncFIIK2 plasmid harboring Tn4401a, was initially identified in
Israel in 2006 (Leavitt et al., 2010), and then this plasmid and
its variants are believed to have spread to Italy, Poland, the UK,
Colombia, the Czech Republic, the USA, and other countries
(Baraniak et al., 2011; Garcia-Fernandez et al., 2012; Hidalgo-
Grass et al., 2012; Warburg et al., 2012; Hrabak et al., 2013b;
Chen et al., 2014d,e), suggesting the wide dissemination of this
plasmid. The blaKPC gene has also been identified in other
non-Tn4401 mobile elements that mostly have partial ISKpn6
genes (Shen et al., 2009; Gomez et al., 2011). Based on the
insertion sequence upstream of the blaKPC gene, they can be
divided into three groups: group I, no insertion (Shen et al.,
2009; Liu et al., 2012; Chen et al., 2014g); group II, insertion of
truncated blaTEM (Gomez et al., 2011); group III, insertion of
Tn5563/IS6100 (Wolter et al., 2009). These non-Tn4401 genetic
elements harboring blaKPC sometimes have an IS26 transposon
(Liu et al., 2012; Chen et al., 2014g).
Carbapenemase genes often spread worldwide through clonal
expansion in several successful pathogenic strains (Chen et al.,
2014e). For example, the dissemination of KPC-producing
K. pneumoniae in most countries including the USA and
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FIGURE 3 | Epidemiological features of NDM-producing K. pneumoniae. (1) India; (2) Pakistan; (3) Bangladesh; (4) Canada; (5) USA; (6) Colombia; (7) Spain;
(8) France; (9) UK; (10) Italy; (11) Switzerland; (12) Greece; (13) Turkey; (14) Saudi Arabia; (15) Oman; (16) United Arab Emirates; (17) Kuwait; (18) Morocco; (19)
South Africa; (20) China; (21) South Korea; (22) Japan; (23) Taiwan; (24) Singapore; (25) Australia; (26) Mexico; (27) Guatemala; (28) Brazil; (29) Ireland; (30) Germany;
(31) Netherlands; (32) Czech Republic; (33) Poland; (34) Hungary; (35) Romania; (36) Croatia; (37) Norway; (38) Sweden; (39) Finland; (40) Russia; (41) Algeria; (42)
Tunisia; (43) Libya; (44) Egypt; (45) Kenya; (46) Madagascar; (47) Mauritius; (48) Israel; (49) Iraq; (50) Iran; (51) Yemen; (52) Sri Lanka; (53) Nepal; (54) Thailand; (55)
Vietnam; (56) Malaysia, (57) New Zealand.
European countries is largely caused by expansion of a single
dominant strain, ST258 (Giani et al., 2013; Chen et al., 2014e;
Bowers et al., 2015). This strain is a prototype of a high-risk clone
of K. pneumoniae. Recent data from Israel showed that the KPC-
producing K. pneumoniae ST258 clone remains the predominant
clone, representing 80% of the KPC-producing K. pneumoniae
population (Adler et al., 2015). ST258 may be a hybrid clone
that was created by a large recombination event between ST11
and ST442 (Pitout et al., 2015). It is unknown why the ST258
lineage is the most prevalent clone of KPC-producing Klebsiella
species. The ST258 clone is highly susceptible to serum killing
in animal models and lacks well-known K. pneumoniae virulence
factors, such as aerobactin genes, K1, K2, and K5 capsular antigen
genes, and the regulator of the mucoid phenotype gene rmpA
(Tzouvelekis et al., 2013; Pitout et al., 2015). Two recent reports
revealed that the ST258 strains consist of two distinct genetic
clades and genetic differentiation between the two clades (-1 and
cps-2) results from an approximately 215-kb region of divergence
that includes cps genes involved in capsule polysaccharide
synthesis (Chen et al., 2014e; Deleo et al., 2014). Multiplex PCR
for the identification of two capsular types in K. pneumoniae
ST258 strains revealed a significant association between the cps
type and KPC variant: the cps-1 clade is largely associated with
KPC-2, while the cps-2 clade is primarily associated with KPC-
3 (Chen et al., 2014a). Because the capsule polysaccharide can
help K. pneumoniae to evade phagocytosis, the global success of
this strain may involve the capsule polysaccharide biosynthesis
regions cps-1 and cps-2. A recent report revealed a relationship
between the integrative conjugative element ICEKp258.2 and the
global success of the ST258 clone (Adler et al., 2014). ICEKp258.2
contains two specific gene clusters, a type IV pilus gene cluster
(i.e., pilV) associated with the uptake and exchange of plasmids
and adherence to living and non-living surfaces, and a gene
cluster of a type III restriction-modification system determining
host specificity in the exchange of certain compatible plasmids
or mobile elements (Adler et al., 2014). Because these genes
associated with the restriction of plasmids and specific mobile
elements were present only in ST258 and genetically related
sequence types, this difference may explain the divergence of
ST258 predominantly harboring KPC and ST11, another high-
risk clone that lacks ICEKp258.2, harboring a broad range of
plasmids and carbapenemases, including KPC, NDM, OXA-
48, VIM, and IMP (Chen et al., 2014f; Pitout et al., 2015).
Although the ICEKp258.2 of ST258 strains may contribute to
global success, the precise reason for the predominance of the
ST258 strain in KPC-producing K. pneumoniae is still not entirely
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FIGURE 4 | Epidemiological features of OXA-48-like-producing K. pneumoniae. (1) Turkey; (2) Morocco; (3) Tunisia; (4) Libya; (5) Egypt; (6) India; (7)
Argentina; (8) Spain; (9) France; (10) Germany; (11) Switzerland; (12) Belgium; (13) Netherlands; (14) UK; (15) Italy; (16) Israel; (17) Saudi Arabia; (18) Kuwait; (19)
Lebanon; (20) Japan; (21) Canada; (22) USA; (23) Ireland; (24) Poland; (25) Finland; (26) Hungary; (27) Romania; (28) Bulgaria; (29) Greece; (30) Russia; (31) Algeria;
(32) Senegal; (33) South Africa; (34) United Arab Emirates; (35) Oman; (36) Iran; (37) Sri Lanka; (38) Thailand; (39) Singapore; (40) South Korea; (41) Taiwan; (42)
Australia; (43) New Zealand.
understood. Recently, an outbreak of non-ST258 KPC-producing
K. pneumoniae clones has been reported in the USA and Europe
(Ruiz-Garbajosa et al., 2013; Bonura et al., 2015; Garbari et al.,
2015).
The habitat of K. pneumoniae is not limited to humans but
extends to the ecological environment, such as soil, water, and
sewage, and K. pneumoniae can survive in extreme environments
for long periods of time (Pitout et al., 2015). Therefore,
K. pneumoniae producing KPCs were detected in various
nosocomial environments, such as gowns and gloves (Rock et al.,
2014) and wastewater (Chagas et al., 2011; Galler et al., 2014).
The frequency of KPC-producing K. pneumoniae contamination
of gowns and gloves of healthcare workers is similar to that of
contamination with methicillin-resistant Staphylococcus aureus
and vancomycin-resistant Enterococcus (Rock et al., 2014),
indicating fast transmission of KPC-producing Klebsiella species
in a nosocomial environment. A long-term observation in
a hospital with low-frequency outbreaks of KPC-producing
K. pneumoniae suggested the possible role of a persisting
environmental reservoir of resistant strains in the maintenance of
this long-term outbreak (Tofteland et al., 2013). After discharge
from the hospital, long-term (>3 years) carriage of KPC-
producing K. pneumoniae is also possible (Lübbert et al., 2014),
and lateral gene transfer of KPC among Enterobacteriaceae
colonizing the human intestine appears frequent, for example
from K. pneumoniae to E. coli (Richter et al., 2011; Gona et al.,
2014). Therefore, reservoirs in healthcare workers, patients, or
the hospital environment may be a principle mode of spread in
nosocomial outbreaks.
Treatment Options
Carbapenemase-producing K. pneumoniae strains are currently
one of the most important nosocomial pathogens. Hospital
outbreaks of KPC-producing K. pneumoniae mainly affect
severely ill patients and are associated with an increased risk of
death (Ducomble et al., 2015; Tumbarello et al., 2015). KPC-
producing K. pneumoniae bloodstream infections in intensive
care unit (ICU) have also been associated with increased
mortality (Chang et al., 2015).
Because carbapenemase-producing K. pneumoniae are mostly
resistant to several important antibiotic classes (β-lactam drugs,
fluoroquinolones, and aminoglycosides), antibiotics, such as
polymyxin B, colistin (polymyxin E), fosfomycin, tigecycline,
and sometimes selected aminoglycosides, are the last-resort
agents. KPC-producing K. pneumoniae are usually resistant to
all β-lactam antibiotics, but temocillin can be active against
some KPC-producing K. pneumoniae, particularly in the case
of lower urinary tract infections (Adams-Haduch et al., 2009).
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To maximize bacterial killing and minimize bacterial resistance,
combined therapy is sometimes recommended. Combination
therapy including a carbapenem, such as a combination of
tigecycline, colistin, and meropenem, was strongly effective in the
treatment of KPC-producing K. pneumoniae, including colistin-
resistant isolates (Tumbarello et al., 2012, 2015; Giamarellou
et al., 2013; Hong et al., 2013; Daikos et al., 2014). The
synergistic combination of colistin and rifampin was also
effective in the treatment of colistin-resistant KPC-producing
K. pneumoniae by slowing the selection of heteroresistant
subpopulations during colistin therapy (Tascini et al., 2013).
However, several reports have shown that combination therapy
was not superior to monotherapy (de Oliveira et al., 2015; Toledo
et al., 2015). Thus, extensive studies will be required to assess
the effectiveness of combination therapy. A triple combination
of colistin-doripenem-ertapenem was effective only in isolates
with high levels of OmpK35 and OmpK36 porin expression
(Hong et al., 2013). The expression level of OmpK36 was
also involved in the rapid induction of high-level carbapenem
resistance in heteroresistant KPC-producing K. pneumoniae
populations (Adams-Sapper et al., 2015). Therefore, molecular
characterization of the KPC-producing K. pneumoniae strain,
such as the determination of the expression level of OmpK35
and OmpK36, can be used to identify effective combination
regimens. However, as a minor effect of OmpK35 and OmpK36
on carbapenem resistance of K. pneumoniae was also reported
(Zhang et al., 2014), more extensive studies on the role of
these proteins on K. pneumoniae carbapenem resistance are also
required.
Colistin (polymyxin E), an agent discovered more than
60 years ago, is a key component of the combination of
antimicrobial regimens used for the treatment of severe KPC-
producing K. pneumoniae infections (Cannatelli et al., 2014b).
Since the global spread of KPC-producing K. pneumoniae,
the emergence of colistin resistance in KPC-producing
K. pneumoniae have been reported in many countries, including
Italy (Cannatelli et al., 2014b; Giani et al., 2015), the USA
(Bogdanovich et al., 2011), Greece (Kontopoulou et al., 2010),
Hungary (Toth et al., 2010), and Turkey (Labarca et al., 2014).
The increasing prevalence of colistin-resistant K. pneumoniae
producing KPC poses a threat to public health because colistin
resistance increases the mortality due to KPC-producing
K. pneumoniae bloodstream infections and reduces therapeutic
options. A multicenter case-control-control study in Italy
showed that the rate of colistin resistance among KPC-producing
K. pneumoniae blood isolates increased more than threefold
during the 4.5-years study period, and the 30-days mortality due
to colistin-resistant KPC-producing K. pneumoniae bloodstream
infections was approximately 51% (Giacobbe et al., 2015). Data
collected from 21 hospital laboratories in Italy between 2013
and 2014 also showed that 43% of carbapenemase-producing
K. pneumoniae were resistant to colistin, 6% were resistant
to tigecycline, 16% were resistant to gentamicin, 82% were
resistant to trimethoprim-sulfamethoxazole, and 1% were
resistant to all four antibiotics, and colistin-resistant isolates
were detected in all participating hospital laboratories (Monaco
et al., 2014). The progressive increase of colistin resistance
was also reported elsewhere (Pena et al., 2014; Bonura et al.,
2015; Parisi et al., 2015). These results indicate that the strict
rules for colistin use are required to diminish the spread of
colistin resistance in the endemic regions of KPC-producing
K. pneumoniae.
Molecular and biochemical studies have shown that
insertional inactivation of the mgrB gene, encoding a negative-
feedback regulator of the PhoQ–PhoP signaling system,
can be responsible for colistin resistance in KPC-producing
K. pneumoniae, due to the resulting up-regulation of the Pmr
lipopolysaccharide modification system (Cannatelli et al., 2013,
2014b). A recent study analyzing a series of colistin-resistant
K. pneumoniae isolates of worldwide origin identified a single
amino acid change (T157P) in the PmrB protein as being
responsible for the overexpression of pmrCAB and pmrHFIJKLM
operons involved in lipopolysaccharide modification, leading
to colistin resistance (Jayol et al., 2014). The relationship
between colistin resistance and inactivation of the mgrB gene
was further supported by analysis of clinical colistin-resistant
K. pneumoniae isolates producing KPC (Bonura et al., 2015;
Giani et al., 2015). The emergence of colistin resistance was also
associated with low-dosage colistin treatment (Cannatelli et al.,
2014a). A recent report showed that the plasmid carrying the
mcr-1 gene, which encodes a phosphoethanolamine transferase
enzyme catalyzing the addition of phosphoethanolamine to lipid
A, is a major contributor to colistin resistance in Gram-negative
bacteria and is spread through horizontal gene transfer (Liu
et al., 2016). This mcr-1-harboring plasmid was also detected in
E. coli isolates collected from 78 (15%) of 523 samples of raw
meat, 166 (21%) of 804 animals, and 16 (1%) of 1322 samples
from inpatients with infection, indicating the emergence of
this plasmid-mediated colistin resistance mechanism (Liu et al.,
2016).
Fosfomycin is a broad-spectrum antibiotic that inhibits
bacterial cell wall biogenesis by inactivating the enzyme UDP-
N-acetylglucosamine-3-enolpyruvyltransferase, also known as
MurA (Brown et al., 1995). Fosfomycin has been used to
treat KPC-producing K. pneumoniae, but recently, a high
fosfomycin resistance rate was observed is in countries with
higher usage (Giske, 2015). Only 43.4% of KPC-producing
K. pneumoniae strains retained susceptibility to fosfomycin in
a Chinese university hospital (Li et al., 2012) and a similar
fosfomycin susceptibility rate (39.2%) was observed in KPC-
producing K. pneumoniae collected from 12 hospitals in China
(Jiang et al., 2015). Like colistin, fosfomycin resistance seems
to be associated with the plasmid containing the fosA3 gene
which encodes glutathione S-transferase to modify fosfomycin
and was characterized first in CTX-M-producing E. coli in Japan
(Wachino et al., 2010). In China, the fosA3-harboring plasmid
was attributed to 55.6% of fosfomycin-resistant KPC-producing
K. pneumoniae strains (Jiang et al., 2015). Although the fosA3
gene is mainly associated with the blaCTX−M gene, the fosA3
gene has also been characterized in atypical blaKPC-harboring
plasmids (Jiang et al., 2015; Li et al., 2015). In pFOS18 (Jiang
et al., 2015) and pKP1034 (Xiang et al., 2015), the fosA3 and
blaKPC−2 genes were located on different transposon systems,
whereas in pHS102707 belonging to the IncP1 group (Li et al.,
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2015), two genes were co-located in the same Tn1721-Tn3-like
transposon.
Tigecycline, a derivative of minocycline, is the first member
of the glycylcycline class that acts as a protein synthesis inhibitor
by blocking the interaction of aminoacyl-tRNA with the A site
of the ribosome (Rose and Rybak, 2006). Due to the increased
clinical use of tigecycline for treatment of KPC-producing
K. pneumoniae, increased tigecycline resistance was reported
(Zagorianou et al., 2012; Papadimitriou-Olivgeris et al., 2014;
Weterings et al., 2015). In the Netherlands, all KPC-producing
K. pneumoniae isolates exhibited reduced susceptibility to
tigecycline (Weterings et al., 2015). Another report showed that
during ICU stay, 17.9% (39/257) of patients became colonized
by tigecycline-resistant KPC-producing K. pneumoniae during
their stay (Papadimitriou-Olivgeris et al., 2014). In a Greek
tertiary hospital during 2004 to 2010, 11.3% (34/301) of KPC-
producing isolates were resistant to tigecycline (Zagorianou et al.,
2012). Overproduction of eﬄux pumps such as AcrAB and
overexpression of RamA, a positive regulator of the AcrAB
eﬄux system, seem to be major factors for decreased sensitivity
of K. pneumoniae strains to tigecycline (Ruzin et al., 2005;
Rosenblum et al., 2011; Sun et al., 2013). A recent report in
China showed that the OqxAB eﬄux pump was also contributed
to tigecycline resistance in K. pneumoniae isolates (Zhong et al.,
2014).
Because KPC-producing K. pneumoniae sometimes remains
susceptible to several aminoglycosides such as gentamicin
(Tzouvelekis et al., 2014), aminoglycosides can be used alone or
in combination therapy to treat KPC-producing K. pneumoniae
infections. Actually, gentamicin monotherapy or in combination
with tigecycline was recently reported to reduce the mortality
from sepsis caused by K. pneumoniae ST512 clone producing
KPC-3, SHV-11, or TEM-1 (Gonzalez-Padilla et al., 2015).
New weapons are always indispensable for combating KPC-
producing K. pneumoniae infections (Lee et al., 2007, 2015a).
The effectiveness of some antibiotics in development was
also estimated against KPC-producing K. pneumoniae. Potent
inhibitors of serine β-lactamases, such as avibactam and
MK7655, were effective against KPC-producing K. pneumoniae
infections (Temkin et al., 2014). Combination therapy with
avibactam and ceftazidime exhibited significant synergetic effects
against organisms with combinations of extended-spectrum
β-lactamases (ESBLs), AmpCs, and KPC-2 (Wang et al.,
2014e). Plazomicin (a novel aminoglycoside) also exhibited
significant activity against KPC-producing K. pneumoniae
(Temkin et al., 2014). The novel polymyxin derivatives with lower
nephrotoxicity are under development (Vaara, 2010). A recent
report suggested that synthetic peptides with antimicrobial and
antibiofilm activities are a promising strategy in the treatment
of infections caused by KPC-producing K. pneumoniae (Ribeiro
et al., 2015). The in vitro activity of the next-generation
aminoglycoside plazomicin alone and in combination with
colistin, meropenem, fosfomycin or tigecycline was tested against
carbapenemase-producing Enterobacteriaceae (CPE) strains.
When plazomicin was combined with meropenem, colistin
or fosfomycin, synergy was observed against CPE isolates
(Rodriguez-Avial et al., 2015).
Detection Methods
Because a delay in the appropriate antibiotic therapy for
severe infections of KPC-producing K. pneumoniae is strongly
associated with unfavorable prognosis and increased mortality
rates (Karaiskos and Giamarellou, 2014), rapid detection of
CR strains is essential for the effective management of these
infections (Lee et al., 2005b, 2006b, 2016). Various methods
for the identification of KPCs have been developed, including
multiplex PCR assay (Spanu et al., 2012; Adler et al., 2014),
real-time PCR assay (Wang et al., 2012; Lee et al., 2015c),
DNA microarray (Peter et al., 2012; Braun et al., 2014), Raman
spectroscopic analysis (Willemse-Erix et al., 2012), single-colony
whole-genome sequencing (Koser et al., 2014), matrix-assisted
laser desorption ionization-time-of-flight mass spectrometry
(MALDI-TOF MS; Carvalhaes et al., 2014), loop-mediated
isothermal amplification (LAMP) method (Nakano et al., 2015),
chromogenic medium (Vrioni et al., 2012), and a new phenotypic
test, called the carbapenem inactivation method (CIM; van der
Zwaluw et al., 2015). False positive results can occur when
the modified Hodge test is used to detect carbapenemases in
carbapenemase-negative K. pneumoniae clinical isolates (Wang
et al., 2011). Therefore, to improve the efficiency in the
phenotypic detection of KPC-producing K. pneumoniae isolates,
the modified Hodge test can be combined with an EDTA
disk test (Yan et al., 2014) or a disk test using boronic acid
compounds (Pournaras et al., 2010a). These methods enhanced
the sensitivity and specificity of KPC detection in K. pneumoniae
isolates. In a new developed phenotypic test, called the CIM, a
susceptibility-testing disk containing carbapenem was immersed
in the suspension made by suspending an inoculation loop
of bacterial culture (van der Zwaluw et al., 2015). After
incubation, the disk was placed on an agar plate inoculated
with a susceptible E. coli indicator strain. If the bacterial isolate
produces carbapenemase, the susceptibility-testing disk will allow
the growth of the susceptible indicator strain. This method
showed high concordance with results obtained by PCR (van
der Zwaluw et al., 2015). Nevertheless, these culture-based
phenotypic tests are time-consuming and cannot easily detect
ESBLs and carbapenemases produced by Enterobacteriaceae,
owing to varied levels of enzyme expression and the poor
specificity of some antibiotic combinations (Okeke et al.,
2011; Swayne et al., 2013). To overcome these limitations
of phenotypic methods, various molecular-based diagnostic
methods have been developed. Especially, the direct detection
of the carbapenemase gene using multiplex PCR, real-time
PCR, and DNA microarray method can increase the speed and
accuracy of detecting CR strains (Okeke et al., 2011; Solanki
et al., 2014). Because of the high genetic diversity of genes
coding for carbapenemase, the precise design of primers or
probes is necessary for correctly amplifying or detecting only
expected carbapenemase genes. Therefore, already developed
methods for bla gene detection are restricted to the detection
of only limited types of bla genes (Lee et al., 2015b). However,
the large-scaleblaFinder was recently developed on the basis
of multiplex PCR, and this large-scale detection method can
detect almost all bla genes, including KPCs, NDMs, OXA-
48-likes, present in bacterial pathogens (Lee et al., 2015b).
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Recently, mass spectrometry-based methods, such as MALDI-
TOF MS and ultra-performance liquid chromatography–tandem
mass spectrometry (UPLC-MS/MS), have been shown to be
capable of characterizing carbapenemase-producing bacteria
(Carricajo et al., 2014; Carvalhaes et al., 2014). These methods
are fast and accurate to routinely identify bacterial isolates
with great specificity and sensitivity (Hrabak et al., 2011;
Patel, 2013; Carvalhaes et al., 2014; Lasserre et al., 2015),
but these systems do not accurately provide the carbapenem
minimum inhibitory concentrations (MICs) for carbapenemase-
producing K. pneumoniae (Patel, 2013). Several experiments
showed that this method is more rapid and accurate for
detection of carbapenemase activity in Gram-negative bacteria
than some methods including the modified Hodge test (Lee
et al., 2013b; Chong et al., 2015). The LAMP method has
emerged as a powerful gene amplification assay for the rapid
identification of microbial infections (Notomi et al., 2000).
This method employs a DNA polymerase and a set of four
specially designed primers that recognize a total of six distinct
sequences on the target DNA. The assay amplifies the DNA
under isothermal conditions (63–65◦C) with high degrees of
specificity, efficiency, and speed (Reddy et al., 2010). The cycling
reaction continues with accumulation of 109 copies of target
in less than an hour. The assay can be conducted in a water
bath or heating block instead of the thermal cycling using a
PCR machine (Notomi et al., 2000). The LAMP assay can be
applied for detection of KPC producers in the clinical laboratory
(Nakano et al., 2015) and has greater sensitivity, specificity, and
rapidity compared to the phenotypic methods and PCR for
the detection of KPC-producing K. pneumoniae (Solanki et al.,
2013).
Colistin has often been used as a therapeutic option for
the treatment of CR K. pneumoniae infections. However,
the imprudent use of colistin has caused rapid spread of
colistin resistance in K. pneumoniae producing carbapenemases,
particularly the KPC-type carbapenemases (Monaco et al., 2014;
Giacobbe et al., 2015). This situation demonstrates the need
for the development of accurate and reliable methods for
detecting colistin resistance. Recently, several methods for the
identification of colistin resistance were reported, including
various routine colistin MIC testing methods, such as BMD,
BMD-P80, AD, Etest, MTS, and Vitek2 (Dafopoulou et al., 2015;
Humphries, 2015); capillary electrophoresis method according to
characteristic surface properties of bacteria (Sautrey et al., 2015);
and the micromax assay based on evaluation of the efficacy of
antibiotics that affect cell wall integrity (Tamayo et al., 2013).
Because a recent report showed that the mcr-1 gene, involved
in the modification of lipid A, is a major contributor to colistin
resistance in Gram-negative bacteria (Liu et al., 2016), detection




Class B β-lactamases are metallo-β-lactamases that require zinc
or another heavy metal for catalysis. Class B β-lactamases have
a broad substrate spectrum and can catalyze the hydrolysis of
virtually all β-lactam antibiotics including carbapenems except
for monobactams (Jeon et al., 2015). Class B carbapenemases
were mostly identified in Enterobacteriaceae and include VIMs,
IMPs, and the emerging NDM group (Jeon et al., 2015). Among
them, NDM (New Delhi metallo-β-lactamase) is one of the most
clinically significant carbapenemases. NDM-1 was first detected
in 2008 in K. pneumoniae and E. coli in a patient returning
to Sweden from India and has since spread worldwide (Yong
et al., 2009; Jeon et al., 2015). Thus far, 15 NDM variants have
been assigned (Jeon et al., 2015), and most of them originated
from Asia (Nordmann and Poirel, 2014). NDMs shares very little
identity with other metallo-β-lactamases (Nordmann and Poirel,
2014).
Since 2008, K. pneumoniae producing NDMs rapidly spread
in many countries (Berrazeg et al., 2014; Figure 3). NDM-
producing K. pneumoniae are considered to be endemic in the
Indian subcontinent, including India, Pakistan, and Bangladesh
(Nordmann et al., 2011b; Nordmann and Poirel, 2014). The
sporadic spread has been reported in the USA (Rasheed et al.,
2013; Centers for Disease Control and Prevention, 2014; Doi
et al., 2014), Canada (Mulvey et al., 2011; Borgia et al., 2012;
Lowe et al., 2013), Colombia (Escobar Perez et al., 2013; Ocampo
et al., 2015), Spain (Oteo et al., 2013b; Seara et al., 2015),
France (Arpin et al., 2012; Robert et al., 2014), Switzerland
(Poirel et al., 2011g; Spyropoulou et al., 2016), Italy (Gaibani
et al., 2011), the UK (Kumarasamy et al., 2010; Giske et al.,
2012), Greece (Voulgari et al., 2014; Spyropoulou et al., 2016),
Turkey (Poirel et al., 2014; Kilic and Baysallar, 2015), Morocco
(Poirel et al., 2011b; Barguigua et al., 2013), South Africa
(Brink et al., 2012; de Jager et al., 2015), Singapore (Chen
et al., 2012; Balm et al., 2013; Ling et al., 2015), Saudi Arabia
(Shibl et al., 2013; Zowawi et al., 2014), Oman (Poirel et al.,
2011a; Zowawi et al., 2014), United Arab Emirates (Sonnevend
et al., 2013; Dash et al., 2014), Kuwait (Jamal et al., 2012,
2013; Sonnevend et al., 2015b), China (Qin et al., 2014; Jin
et al., 2015; Liu et al., 2015), Japan (Yamamoto et al., 2013;
Nakano et al., 2014), Taiwan (Chiu et al., 2013; Tseng et al.,
2015), South Korea (Kim et al., 2012; Cho et al., 2015), and
Australia (Shoma et al., 2014; Wailan et al., 2015). In India,
NDM-1 was the most common carbapenemase type detected
and accounted for 75.22% of the carbapenemase-producing
isolates (Kazi et al., 2015). In Singapore and the United Arab
Emirates, NDM-1 also was the most common carbapenemase
type observed (44.4 and 100%, respectively; Dash et al., 2014;
Ling et al., 2015). The endemic spread of NDM-producing
K. pneumoniae has also been reported in the UK, which has
close relationships with India and Pakistan (Nordmann and
Poirel, 2014). In China, NDM-1 has been found mostly in
Acinetobacter spp., but data obtained from patients between
June 2011 and July 2012 showed that 33.3% of the CRE
isolates, including K. pneumoniae, had NDM-1, suggesting the
possible transmission of blaNDM−1-containing sequences from
Acinetobacter spp. to Enterobacteriaceae (Qin et al., 2014).
These findings reveal the emergence and active transmission
of NDM-1-producing K. pneumoniae in China. Comparative
analyses of the conserved NDM-1-encoding region among
different plasmids from K. pneumoniae and E. coli suggested that
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the transposable elements and two unknown inverted repeat-
associated elements flanking the NDM-1-encoding region aided
the spreading of this resistance determinant (Chen et al., 2012).
Recently, in China, eight K. pneumoniae isolates producing
NDM-1 were identified in the neonatal ward of a teaching
hospital (Zhang et al., 2015), and four diverse types (NDM-1,
KPC-2, VIM-2, and IMP-4) of carbapenemase of K. pneumoniae
clones were identified in a single hospital in China (Liu et al.,
2015).
The Balkan states (Livermore et al., 2011; Voulgari et al.,
2014), the Arabian Peninsula (Nordmann and Poirel, 2014),
and North African countries (Dortet et al., 2014c), have also
been recently considered as an additional reservoir of NDM
producers. In the Arabian Peninsula, NDM-1 was the most
frequently encountered carbapenemase (46.5%) followed by
OXA-48-like carbapenemases (32.5%; Sonnevend et al., 2015b).
In Greece, among 132 non-repetitive CRE isolates between
2010 and 2013, 78 K. pneumoniae isolates with the blaNDM−1
gene were identified (Voulgari et al., 2014). In the USA, KPC-
producing K. pneumoniae have been responsible for much of
the increase in carbapenemase-producing bacteria detection, but
recent increases in NDM-producing K. pneumoniae have the
potential to add to this burden (Rasheed et al., 2013; Centers for
Disease Control and Prevention, 2014).
The movement of patients between countries may be a
trigger for the international spread of carbapenemase-producing
K. pneumoniae (Berrazeg et al., 2014). Carbapenemase-
producing Gram-negative bacteria including K. pneumoniae,
obtained from patients that had recently traveled outside Canada
between 2010 and 2013, were found to be NDM-producing
K. pneumoniae, belonging to various sequence types (ST15, ST16,
ST147, ST258, ST340, ST512, and ST972) with different plasmids
(IncF, IncA/C, and IncL/M), and were imported from India to
Canada (Peirano et al., 2014). Therefore, more careful attention
is required when treating patients with a recent history of foreign
hospitalization in countries where carbapenemase-producing
bacteria are prevalent. The international transportations of
patients between countries recently resulted in the detection of
NDM-producing K. pneumoniae in Mexico (Barrios et al., 2014),
Guatemala (Pasteran et al., 2012), Brazil (Quiles et al., 2015),
the Netherlands (Bathoorn et al., 2015), Ireland (McDermott
et al., 2012), Poland (Baraniak et al., 2016), Czech Republic
(Studentova et al., 2015), Croatia (Kocsis et al., 2016), Russia
(Ageevets et al., 2014), Tunisia (Ben Nasr et al., 2013), Romania
(Lixandru et al., 2015), Egypt (Bathoorn et al., 2013), Kenya
(Poirel et al., 2011f), Madagascar (Chereau et al., 2015), Iraq
(Poirel et al., 2011e), Yemen (Gharout-Sait et al., 2014), Iran
(Shahcheraghi et al., 2013), Mauritius (Poirel et al., 2012b), Sri
Lanka (Dortet et al., 2013), Thailand (Rimrang et al., 2012),
Nepal (Tada et al., 2013), Vietnam (Hoang et al., 2013), Malaysia
(Al-Marzooq et al., 2015), and New Zealand (Williamson et al.,
2012).
The global dissemination of NDM-producing K. pneumoniae
also has a serious impact on neonatal mortality rates, particularly
in low-income countries where the burden of neonatal sepsis
is high (Zaidi et al., 2005). Colonization of NDM-producing
K. pneumoniae isolates in pregnant women in the community
in Madagascar highlighted the potential for mother-to-child
transmission (Chereau et al., 2015). In India, analysis of
Enterobacteriaceae, including K. pneumoniae, isolated from
the blood of septicaemic neonates, indicted that 14% of the
isolates possessed blaNDM−1, and there was a significantly higher
incidence of sepsis caused by NDM-1-harboring isolates (Datta
et al., 2014). In China, an outbreak of blaNDM−1-producing
K. pneumoniae ST20 and ST17 isolates was identified in a
neonatal unit (Jin et al., 2015). In Turkey, the spread of NDM-1-
producing K. pneumoniae in a neonatal ICU was reported (Poirel
et al., 2014). In Colombia, NDM-1-producing K. pneumoniae
strains were identified from an outbreak that affected six neonatal
patients (Escobar Perez et al., 2013).
As with KPC, coexistence of NDMs and other carbapenemases
in K. pneumoniae has also been reported worldwide, in Brazil
(NDM-1/KPC-2; Pereira et al., 2015), Malaysia (NDM-1/OXA-
232; Al-Marzooq et al., 2015), South Korea (NDM-5/OXA-181;
Cho et al., 2015), China (NDM-1/IMP-4; Chen et al., 2015), India
(NDM-1/OXA-232; Al-Marzooq et al., 2015), Turkey (NDM-
1/OXA-48; Kilic and Baysallar, 2015), Pakistan (NDM-1/KPC-
2; Sattar et al., 2014), Switzerland (NDM-1/OXA-48; Seiffert
et al., 2014), United Arab Emirates (NDM-1/OXA-48-like; Dash
et al., 2014), Australia (NDM-1/OXA-48; Sidjabat et al., 2015),
Morocco (NDM-1/OXA-48; Barguigua et al., 2013), Singapore
(NDM-1/OXA-181 and NDM-5/OXA-181; Balm et al., 2013),
and the USA (NDM-1/OXA-232; Doi et al., 2014).
Besides NDM-type carbapenemases, the IMP and VIM groups
have also been detected worldwide in K. pneumoniae, but
other carbapenemases, such as GIM-1, KHM-1, and SPM-1,
have been not found in K. pneumoniae (Table 1). Since IMP
and VIP were first detected in Serratia marcescens in 1991
and in Pseudomonas aeruginosa in 1996, respectively (Osano
et al., 1994; Lauretti et al., 1999), IMP- and VIM-producing
K. pneumoniae have spread in Europe and Asia, but were rarely
reported in other regions, such as America and Africa (Table 1).
Although in this review we have focused only on carbapenemase-
producing K. pneumoniae, the VIM group is one of the most
commonly reported carbapenemases worldwide if we consider all
bacteria species (the VIM groups have been mainly identified in
P. aeruginosa; Poirel et al., 2007).
Molecular and Genetic Context
The blaNDM gene is frequently observed in the transposon
Tn125 (with two flanking ISAba125 elements) within NDM-
producing species of the genus Acinetobacter (Partridge and
Iredell, 2012; Wailan et al., 2015). The blaNDM gene was
hypothesized to originate in the genus Acinetobacter (Toleman
et al., 2012). In Enterobacteriaceae, the ISAba125 elements of
the Tn125 structure carrying blaNDM are frequently truncated
(Tn125) at various lengths and the Tn125 structure frequently
has different IS elements (Figure 2B; Partridge and Iredell,
2012; Wailan et al., 2015). The blaNDM genes in K. pneumoniae
have been reported on numerous broad-host-range plasmid
types, including IncA/C (Hudson et al., 2014), IncF (Hishinuma
et al., 2013), IncR (Studentova et al., 2015), IncH (Villa
et al., 2012), IncN (Chen et al., 2014a), IncL/M (Peirano
et al., 2014), and IncX types (Wang et al., 2014d). The
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predominant plasmid type responsible for spreading blaNDM−1
is the IncA/C type plasmids (Poirel et al., 2011d; Pitout
et al., 2015). Many IncA/C plasmids with blaNDM−1 also
carry various antibiotic resistance genes including 16S rRNA
methylases (RmtA and RmtC), associated with aminoglycoside
resistance; CMY-type β-lactamases, associated with broad-
spectrum cephalosporin resistance; and QnrA, associated with
quinolone resistance (Pitout et al., 2015). Consequently, many
NDM-producing K. pneumoniae were susceptible only to
colistin, fosfomycin, and tigecycline (Nordmann and Poirel,
2014). A novel NDM-1 variant (NDM-9) located on a novel
IncH variant plasmid was recently identified in a clinical
K. pneumoniae isolate in China (Wang et al., 2014c). Because
the blaNDM genes are located in numerous broad-host-range
plasmids, the spread of NDM-1 is facilitated by horizontal
gene transfer between bacteria. In China, CRE 21 strains
harboring the blaNDM−1 gene were found to consist of multiple
Enterobacteriaceae species including nine Enterobacter cloacae,
three E. coli, three Citrobacter freundii, two K. pneumoniae, two
K. oxytoca, and two Morganella morganii strains (Wang et al.,
2015).
Unlike KPC, the blaNDM genes were detected in various
K. pneumoniae clones. ST11, a major high-risk sequence type of
KPC-producing K. pneumoniae in Asia, has also been associated
with blaNDM−1 in K. pneumoniae identified in many countries,
such as the USA (Rasheed et al., 2013), Greece (Voulgari et al.,
2014), Australia (Shoma et al., 2014), Switzerland (Seiffert et al.,
2014), the Czech Republic (Studentova et al., 2015), Spain
(Oteo et al., 2013b), and Thailand (Netikul et al., 2014). The
recent outbreak of NDM-producing K. pneumoniae ST11 in
Poland was caused by a clone similar to an isolate identified in
the Czech Republic in 2013 (Baraniak et al., 2016), indicating
the local spread of this clone. ST11 has also been associated
with OXA-48-like enzymes from isolates found in Argentina,
Turkey, and Spain (Lascols et al., 2013; Oteo et al., 2013b).
ST14, ST147, and ST340 have sometimes been associated with
blaNDM in K. pneumoniae in many countries (Peirano et al.,
2011, 2014; Poirel et al., 2011d; Giske et al., 2012; Osterblad
et al., 2012; Lascols et al., 2013; Gharout-Sait et al., 2014;
Lee et al., 2014; Shoma et al., 2014; Wang et al., 2014d;
Izdebski et al., 2015; Sonnevend et al., 2015b). Over 50% of
NDM-producing K. pneumoniae isolates from India belonged
to either ST11 or ST147 (Lascols et al., 2013). The analysis
of clinical isolates of NDM-1-producing K. pneumoniae from
India, the UK, and Sweden, showed that the most frequently
detected sequence types were ST14, ST11, ST149, ST231,
and ST147 (Giske et al., 2012). Although ST258 is a high-
risk KPC-producing K. pneumoniae clone, ST258 harboring
blaNDM has never been reported, to the best of our knowledge.
This phenomenon may result from the integrative conjugative
element ICEKp258.2, present only in ST258 and genetically
related sequence types (Adler et al., 2014). This genetic locus
contains a type IV pilus gene cluster and a type III restriction-
modification system. Because these genes are associated with
the restriction of plasmids and specific mobile elements, most
ST258 may predominantly harbor plasmids with the blaKPC
gene. Therefore, PCR for this unique region (ICEKp258.2) can
provide a reliable tool for the rapid detection of the ST258
clone.
High-resolution genomic analysis of multidrug-resistant
hospital outbreaks of K. pneumoniae through whole-genome
sequencing revealed the emergence of a capsule switching NDM-
1 bearing K. pneumoniae ST15 strain, suggesting that further
studies should concentrate on the diversity and spread of this
specific clone (Chung The et al., 2015). ST15 harboring blaNDM−1
has often been reported in many countries, including Spain
(Ruiz-Garbajosa et al., 2013), Croatia (Kocsis et al., 2016),
Thailand (Netikul et al., 2014), Canada (Peirano et al., 2014),
China (Hu et al., 2013), France (Arpin et al., 2012), and Morocco
(Poirel et al., 2011b). In Bulgaria, this clone was responsible for
the clonal dissemination of KPC-2-producing K. pneumoniae
(Markovska et al., 2015). Another whole-genome sequencing
analysis of CR K. pneumoniae strains, which were isolated
from 26 individuals involved in infections in a Nepali neonatal
unit, showed that three temporally separated cases were caused
by a single NDM-producing K. pneumoniae strain with four
conserved plasmids including a plasmid carrying blaNDM−1
(Stoesser et al., 2014). The plasmids contained a large number
of antimicrobial resistance and plasmid maintenance genes,
which may explain their persistence (Stoesser et al., 2014). These
reports suggest that whole-genome sequencing analysis play
an important role in the elucidation of the factors that allow
emergence and persistence of resistance.
Treatment Options
New-Delhi metallo-β-lactamase-producing K. pneumoniae are
usually resistant to most β-lactam antibiotics but remain
susceptible to aztreonam (Nordmann et al., 2012a). As with
the case of KPC-producing K. pneumoniae, the effect of
combination therapy was tested in the treatment of NDM-
producing K. pneumoniae infections. When double- and triple-
antibiotic combinations of aztreonam, ciprofloxacin, colistin,
daptomycin, fosfomycin, meropenem, rifampin, telavancin,
tigecycline, and vancomycin were used in patients infected
with two NDM-producing K. pneumoniae strains susceptible
to colistin, the combination of rifampin-meropenem-colistin
was the most effective regimen against these strains (Tangden
et al., 2014). The in vitro synergetic effect of the combination
therapy of colistin and fosfomycin against NDM-producing
K. pneumoniae has also been reported (Bercot et al., 2011).
The combination of polymyxin B and chloramphenicol used
against NDM-producing K. pneumoniae substantially enhanced
bacterial killing and suppressed the emergence of polymyxin
resistance (Abdul Rahim et al., 2015). Combination therapy
including aztreonam and avibactam (a novel inhibitor of serine
β-lactamases under development) was effective in the treatment
of metallo-β-lactamase-producing bacterial infections (Wang
et al., 2014e).
In the case of NDM-1-producing Enterobacteriaceae
infections, carbapenems have been suggested to still represent
a viable treatment option (Wiskirchen et al., 2014b).
Despite unfavorable in vitro MICs of NDM-producing
K. pneumoniae, recent in vivo studies have demonstrated
the efficacy of carbapenems against NDM-1-producing isolates
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in immunocompetent-mouse and neutropenic-mouse thigh
infection models (Wiskirchen et al., 2013, 2014b; MacVane
et al., 2014). Although high-dose, prolonged infusions of
ertapenem or doripenem induced reduction in bacterial density,
bacterial density was also reduced in standard infusions of
ertapenem at 1 g every 24 h or of doripenem at 500 mg every
8 h (Wiskirchen et al., 2013, 2014b). Notably, these efficacies
were observed only against NDM-1-producing K. pneumoniae
(Wiskirchen et al., 2013, 2014b). In addition to carbapenems,
this discordance between in vitro and in vivo activities against
NDM-1-producing K. pneumoniae was also observed in
human simulated regimens of ceftazidime at 2 g every 8 h or
ceftazidime/avibactam at 2,000/500 mg every 8 h (MacVane
et al., 2014). Despite experiments in immunocompetent-mouse
and neutropenic-mouse thigh infection models, these results
show that standard infusions of ertapenem and doripenem
could reduce bacterial density. Therefore, further experiments
in human are required to determine whether carbapenems are
sometimes a viable treatment option for NDM-1-producing
K. pneumoniae infections.
The copy number of blaNDM−1 was assessed using Southern
blotting and quantitative PCR under different conditions. The
blaNDM−1 sequence was maintained under antibiotic selection;
however, removal of the antibiotic selection led to the emergence
of susceptible bacterial populations with a reduced copy number
or even the complete loss of the blaNDM−1 gene (Huang
et al., 2013). The dynamic nature of the copy number of
blaNDM−1 provides a strong argument for the prudent use of
clinically important antibiotics to reduce the development and
dissemination of antibiotic resistance among pathogenic bacteria
(Huang et al., 2013).
Detection Methods
Because NDM-producing K. pneumoniae infections are also
associated with significant in-hospital mortality (de Jager et al.,
2015), the rapid and accurate detection of NDM-producing
K. pneumoniae is becoming a major issue in limiting the spread
of CR bacteria. Several methods recently developed to detect
NDM-producing K. pneumoniae include Xpert R© Carba-R based
on real time PCR (Anandan et al., 2015), the Carba NP test
based on the color change of a pH indicator (Nordmann et al.,
2012b), and its derivatives (Pires et al., 2013; Dortet et al.,
2014b), and a method based on MALDI-TOF (Hrabak et al.,
2013a). Xpert R© Carba-R based on real time PCR effectively
identified various carbapenemases of KPC, NDM, IMP, and
VIM, with 100% sensitivity and 77% specificity (Anandan et al.,
2015). However, this method failed to detect OXA-48-like
carbapenemases, in contrast to multiplex PCR (Anandan et al.,
2015).
The Carba NP test using chromogenic medium is based on
the color change of a pH indicator (Nordmann et al., 2012b).
The enzymatic hydrolysis of the β-lactam ring of a carbapenem
(usually imipenem) causes the acidification of an indicator
solution (phenol red for the Carba NP test) that changes its
color due to pH modification (Garcia-Fernandez et al., 2016).
This method could rapidly detect KPC, IMP, VIM, NDM, and
OXA-48-like producers with sensitivity and specificity of 97.9
and 100%, respectively, directly from spiked blood cultures
(Dortet et al., 2014a). Comparative evaluation of the Carba
NP test with other detection methods was tested in many
reports (Vasoo et al., 2013; Huang et al., 2014; Yusuf et al.,
2014; Gallagher et al., 2015; Lifshitz et al., 2016). When the
Carba NP test and the modified Hodge test were compared,
the Carba NP test was more specific (100% versus 80%) and
faster (Vasoo et al., 2013; Huang et al., 2014; Yusuf et al.,
2014). When it was compared the performance of the Carba
NP test and the commercially available imipenem hydrolysis-
based rapid test (the Rosco Rapid CARB screen kit) for detecting
CPE and P. aeruginosa, the Carba NP test showed superior
specificity and sensitivity (Huang et al., 2014; Yusuf et al.,
2014; Gallagher et al., 2015). A novel simplified protocol of
the Carba NP test designed for carbapenemase detection direct
from bacterial cultures (instead of bacterial extracts) showed
enhanced detection of carbapenemase producers (Pasteran et al.,
2015).
However, several reports showed that false-negative results
in the Carba NP test were associated with mucoid strains or
linked to enzymes with low carbapenemase activity, particularly
OXA-48-like (Tijet et al., 2013; Osterblad et al., 2014). To
overcome these problems, several derivatives of the Carba
NP test were developed, such as the Rapidec Carba NP test
(bioMérieux; Poirel and Nordmann, 2015), the CarbAcineto
NP test for rapid detection of carbapenemase-producing
Acinetobacter spp. (Dortet et al., 2014b), the Rapid CARB
Screen (Rosco Diagnostica; Dortet et al., 2015), the Blue-
Carba test using bromothymol blue as a pH indicator
solution (Garcia-Fernandez et al., 2016), a modified Carba
NP test (Bakour et al., 2015a), and the BYG Carba test
based on an electro-active polymer biosensing technology
(Bogaerts et al., 2016). Many studies evaluated the performance
of the Rapidec Carba NP test (bioMérieux), which was
introduced into the market for the detection of carbapenemase
production (Dortet et al., 2015; Hombach et al., 2015; Kabir
et al., 2016; Lifshitz et al., 2016). These report showed
that this method was user-friendly and had a high overall
performance, making it an attractive option for clinical
laboratories (Kabir et al., 2016). Recently, performance evaluation
of two biochemical rapid tests commercialized (the Rapidec
Carba NP test and the Rapid CARB Screen) was reported
and compared with the home-made Carba NP test (Dortet
et al., 2015). The Rapidec CARBA NP test possesses the
best performance for rapid and efficient detection of CPE
(Dortet et al., 2015). The BYG Carba test based on a new
and original electrochemical method detects the variations of
conductivity of a polyaniline (an electro-sensing polymer)-
coated electrode which is highly sensitive to the modifications
of pH and of redox activity occurring during the imipenem
enzymatic hydrolysis reaction (Bogaerts et al., 2016). In
comparison with PCR results, the BYG Carba test displayed
sensitivity of 95% and specificity of 100% versus 89% and
100%, respectively, for the Carba NP test (Bogaerts et al.,
2016). The development of these detection methods based on
inexpensive and affordable techniques can limit the spread of CR
bacteria.
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Class D Carbapenemases
Epidemiology
Class D β-lactamases were referred to as oxacillinases (OXAs)
because they commonly hydrolyze isoxazolylpenicillins
(oxacillin, cloxacillin, and dicloxacillin) much faster than
benzylpenicillin (Jeon et al., 2015). Of over 400 Class D
β-lactamases, only some variants actually possess carbapenemase
activity. Based on their amino acid sequence, class D
carbapenemases were recently reclassified into 12 subgroups:
OXA-23, OXA-24/40, OXA-48, OXA-51, OXA-58, OXA-134a,
OXA-143, OXA-211, OXA-213, OXA-214, OXA-229, and OXA-
235 (Jeon et al., 2015). Among them, only several subgroups
such as OXA-23, OXA-48, OXA-51, and OXA-58 are reported
in K. pneumoniae (Evans and Amyes, 2014). OXA-48 is the most
efficient class D carbapenemase for imipenem and is one of the
most prevalent class D carbapenemases (Jeon et al., 2015). The
OXA-48 was first identified in K. pneumoniae in Turkey in 2003
(Poirel et al., 2004), and thus far, 10 variants of the blaOXA−48
gene have been identified (Jeon et al., 2015). Turkey may be one
of the main reservoirs of OXA-48-producing K. pneumoniae
(Nordmann and Poirel, 2014). Since 2003, the endemic spread
of these bacteria has been reported in countries such as Turkey,
Morocco, Libya, Egypt, Tunisia, and India (Nordmann and
Poirel, 2014; Figure 4). The sporadic spread has been reported
in France (Liapis et al., 2014; Semin-Pelletier et al., 2015), Spain
(Oteo et al., 2013b; Pena et al., 2014), Italy (Giani et al., 2013,
2014), Belgium (Cuzon et al., 2008; Huang et al., 2013), the
Netherlands (Kalpoe et al., 2011; Dautzenberg et al., 2014), the
UK (Dimou et al., 2012; Thomas et al., 2013), Germany (Pfeifer
et al., 2012; Kola et al., 2015), Switzerland (Potron et al., 2012;
Seiffert et al., 2014), Argentina (Poirel et al., 2011c; Lascols et al.,
2013), Lebanon (Beyrouthy et al., 2014), Israel (Adler et al.,
2013, 2015), Kuwait (Poirel et al., 2012a; Zowawi et al., 2014),
Saudi Arabia (Shibl et al., 2013; Liu et al., 2015), and Japan
(Nagano et al., 2013; Hashimoto et al., 2014). The prevalence
of OXA-48 carbapenemases among carbapenemase-producing
K. pneumoniae in Spain and France was particularly high (74
and 78%, respectively; Robert et al., 2014; Palacios-Baena et al.,
2016). In Africa, OXA-48-producing K. pneumoniae have been
mainly reported in the northern countries, such as Morocco,
Libya, Egypt, Tunisia, and Algeria (Figure 4). In the Arabian
Peninsula, the prevalence of OXA-48-like carbapenemases
among carbapenemase-producing K. pneumoniae was also high
(32.5–56%; Zowawi et al., 2014; Sonnevend et al., 2015b). Among
CRE isolates in Lebanon, 88% produced OXA-48 carbapenemase
(Beyrouthy et al., 2014). In Saudi Arabia, 78% of carbapenemase-
producing K. pneumoniae isolates harbored blaOXA−48, and
three strains of 47 blaOXA−48-positive K. pneumoniae isolates
were resistant to colistin, suggesting that colistin resistance is
emerging in Saudi Arabia (Shibl et al., 2013).
In France, examination of the epidemiologic features of
an outbreak of OXA-48-producing K. pneumoniae in an
ICU revealed that the outbreak was caused by environmental
persistence of OXA-48-producing K. pneumoniae over 20 months
(Pantel et al., 2016). This report emphasizes the importance of
early environmental screening to interrupt the transmission of
carbapenemase-producing K. pneumoniae (Pantel et al., 2016).
Similarly, a large outbreak of OXA-48 carbapenemase-producing
K. pneumoniae in a French university hospital was recently
attributed to the late implementation of successive cohort units
and a high level of staff movement between the infectious
diseases and internal medicine ward (Semin-Pelletier et al.,
2015). These results suggest that practical guidelines are required
to help hospitals confronting uncontrolled outbreaks. Because
the gut of colonized patients is the main source of CPE,
accurate and stringent hygiene of endoscopic instruments is
also important. A recent report partially attributed an outbreak
of OXA-48-producing K. pneumoniae in a German University
hospital to complex instruments such as the duodenoscope (Kola
et al., 2015). Strict hygiene regulations for various nosocomial
environments, including endoscopic instruments as well as
gowns and gloves, are required.
OXA-48-producing K. pneumoniae was recently also detected
in Canada (Ellis et al., 2013), the USA (Mathers et al., 2013),
Ireland (Wrenn et al., 2014), Poland (Izdebski et al., 2015),
Hungary (Janvari et al., 2014), Greece (Voulgari et al., 2013),
Romania (Lixandru et al., 2015), Bulgaria (Markovska et al.,
2015), Finland (Osterblad et al., 2012), Russia (Fursova et al.,
2015), Algeria (Cuzon et al., 2015), United Arab Emirates
(Ahn et al., 2015), Iran (Azimi et al., 2014), South Africa
(Brink et al., 2013), Senegal (Moquet et al., 2011), Taiwan
(Ma et al., 2015), Singapore (Ling et al., 2015), South Korea
(Jeong et al., 2015), and Australia (Espedido et al., 2013;
Figure 4). In North America, the frequency of OXA-48-
like enzymes among carbapenemase-producing K. pneumoniae
isolates was very low (11%; Lascols et al., 2013). A recent report
in Romania showed that among 65 carbapenemase-producing
K. pneumoniae, the most frequently identified gene was the
blaOXA−48 gene (78%), 12% were positive for blaNDM−1 gene, 6%
had the blaKPC−2 gene (Lixandru et al., 2015). The recent spread
of OXA-48 and OXA-244 carbapenemase genes in Russia was
reported among Proteus mirabilis, E. aerogenes, and E. cloacae
as well as K. pneumoniae (Fursova et al., 2015). In South
Africa, the emergence of a colistin-resistant OXA-181-producing
K. pneumoniae isolate was also reported (Brink et al., 2013),
and in the Netherlands, an OXA-48-producing K. pneumoniae
was reported to infect two patients (Kalpoe et al., 2011), and a
hospital-wide outbreak was successfully controlled (Dautzenberg
et al., 2014).
OXA-181, a derivative of OXA48 with the substitution of
a single amino acid, was first identified in India in Potron
et al. (2011), and then has been spread to many different
countries, such as the UK (Dimou et al., 2012), Romania
(Székely et al., 2013), Canada (Peirano et al., 2014), Oman
(Potron et al., 2011), Singapore (Balm et al., 2013), Sri Lanka
(Hall et al., 2014), South Korea (Cho et al., 2015), Australia
(Sidjabat et al., 2015), Japan (Kayama et al., 2015), and New
Zealand (Williamson et al., 2011). However, in many cases,
the infections have been associated with India (Potron et al.,
2011; Williamson et al., 2011; Dimou et al., 2012; Hall et al.,
2014; Peirano et al., 2014). Other OXA-48-derivatives, such as
OXA-204 (Potron et al., 2013), OXA-232 (Potron et al., 2013),
and OXA-163 (Poirel et al., 2011b), were recently identified in
Tunisia, France, and Argentina, respectively, and OXA-244 and
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OXA-245 were first reported in Spain (Oteo et al., 2013a). All
of these countries are regions with a high prevalence of OXA-
48-producing K. pneumoniae (Figure 4). In addition, OXA-232-
producing K. pneumoniae has been reported in various countries,
such as the USA (Doi et al., 2014), Singapore (Teo et al., 2013),
India (Al-Marzooq et al., 2015), and South Korea (Jeong et al.,
2015). These results indicate that besides OXA-48, its many
derivatives also spread worldwide. OXA-163, which differs from
OXA-48 by a four amino acid deletion and a single amino acid
substitution, has lower carbapenemase activity than OXA-48,
but this enzyme exhibits extended activity against expanded-
spectrum cephalosporins, and its activity is partially inhibited
by clavulanic acid, a β-lactamase inhibitor (Poirel et al., 2011c).
OXA-247, a derivative of OXA-163 with a single amino acid
substitution, was recently reported in Argentina (Gomez et al.,
2013), where OXA-163-producing K. pneumoniae were often
reported (Lascols et al., 2013).
The coexistence of OXA-48-like and other carbapenemases in
K. pneumoniae was also frequently reported worldwide, such as in
Turkey (OXA-48/NDM-1; Kilic and Baysallar, 2015), Switzerland
(OXA-48/NDM-1; Seiffert et al., 2014), United Arab Emirates
(OXA-48-like/NDM-1; Dash et al., 2014), Australia (OXA-
48/ NDM-1; Sidjabat et al., 2015), Morocco (OXA-48/NDM-1;
Barguigua et al., 2013), India (OXA-181/VIM-5; Castanheira
et al., 2011), Singapore (OXA-181/NDM-1 and OXA-181/NDM-
5; Balm et al., 2013), the USA (OXA-232/NDM-1; Doi et al.,
2014), and India (OXA-232/NDM-1; Al-Marzooq et al., 2015).
Other class D carbapenemases, such as OXA-23, OXA-24/40,
OXA-51, OXA-58, OXA-134a, OXA-143, OXA-211, OXA-213,
OXA-214, OXA-229, and OXA-235, were mainly identified
in Acinetobacter species such as A. baumannii but not in
K. pneumoniae (Table 1; Evans and Amyes, 2014).
Molecular and Genetic Context
Unlike KPCs and NDMs, one highly transferable IncL group
plasmid (pOXA-48a) was mainly responsible for the spread of
the blaOXA−48 gene in K. pneumoniae (Figure 2C; Pitout et al.,
2015). The molecular epidemiology of OXA-48 in European and
North African countries showed that in 92.5% of the isolates,
the blaOXA−48 gene was located on this self-conjugative IncL/M
type plasmid (Potron et al., 2013). The blaOXA−48 gene was
found only in the IncL group of IncL/M type plasmids (Carattoli
et al., 2015). In contrast to the IncA/C plasmids of NDM-1,
the pOXA-48a plasmid contains blaOXA−48, a unique antibiotic
resistance gene (Pitout et al., 2015). The conjugation rate of the
pOXA-48a plasmid was very high (1× 10−1); therefore, this self-
conjugative plasmid can conjugate at a very high frequency to
Enterobacteriaceae (Potron et al., 2014). Inactivation of the tir
gene, which is known to encode a transfer inhibition protein,
was recently reported to be responsible for a 50- to 100-fold
increase in the efficiency of transfer of the pOXA-48a plasmid
(Potron et al., 2014), explaining the spread of the pOXA-48a
plasmid with blaOXA−48. Recently, the blaOXA−48−like gene has
also been reported on other plasmids and genetic elements, such
as IncA/C types (Ma et al., 2015), IncH types (Wang et al.,
2014c), and Tn1999 (Poirel et al., 2012a). In comparison to the
pOXA-48a plasmid, the transmission frequency of the Tn1999
composite transposon was very low (<1.0 × 10−7; Aubert et al.,
2006).
OXA-48 has most often been found in K. pneumoniae, but
OXA-48 was also found in various Enterobacteriaceae, because
of the high conjugation rate of the pOXA-48a (Potron et al.,
2014). Molecular and epidemiological analyses in a German
hospital showed the horizontal gene transfer of the OXA-48-
containing plasmid from K. pneumoniae to E. coli (Gottig et al.,
2015). Besides E. coli, OXA-48 has also been identified in
K. oxytoca, Enterobacter spp., Providencia rettgeri, C. freundii,
and S. marcescens (Poirel et al., 2012c; Berger et al., 2013). The
blaOXA−48 gene was identified in all Enterobacteriaceae isolates
from the index case in Spain, indicating the capacity of OXA-
48 carbapenemase to spread among Enterobacteriaceae by the
horizontal gene transfer (Arana et al., 2015).
Similar to NDM, the blaOXA−48−like genes were detected in
various K. pneumoniae clones. ST11 has often been associated
with blaOXA−48−like in K. pneumoniae isolated in many countries,
such as Spain (Oteo et al., 2013a,b, 2015; Ruiz-Garbajosa et al.,
2013; Branas et al., 2015), Taiwan (Ma et al., 2015), Libya
(Lafeuille et al., 2013), Turkey (Lascols et al., 2013), Argentina
(Lascols et al., 2013), and Greece (Voulgari et al., 2013). In Spain,
a large outbreak was initiated in 2013 by a OXA-48-producing
K. pneumoniae ST11 clone, and this strain was detected in 44
patients (Branas et al., 2015). The ST11 isolates carried various
carbapenemases, including NDM-1, VIM-1, OXA-48, KPC-2,
and OXA-245 (Lascols et al., 2013; Oteo et al., 2013b, 2015).
In addition, ST14, ST15, ST101, ST147, and ST405 harboring
blaOXA−48−like have often been reported in many countries, such
as the USA (Lascols et al., 2013), Spain (Oteo et al., 2013b, 2015;
Ruiz-Garbajosa et al., 2013; Arana et al., 2015; Cubero et al.,
2015), the Czech Republic (Hrabak et al., 2015), Libya (Lafeuille
et al., 2013), India (Lascols et al., 2013), Germany (Gottig et al.,
2015), Finland (Osterblad et al., 2012), France (Liapis et al.,
2014), and Japan (Hashimoto et al., 2014). Recent results from
83 hospitals in Spain showed that OXA-48 (71.5%) and VIM-
1 (25.3%) were the most frequently detected carbapenemases,
and the most prevalent sequence types were ST11 and ST405
for K. pneumoniae (Oteo et al., 2015). However, the molecular
epidemiology of OXA-48-producing enterobacterial isolates
collected from European and north-African countries between
2001 and 2011 indicated that ST101 was the most commonly
observed sequence type in K. pneumoniae isolates, accounting for
17 out of 67 isolates (25.4%), followed by ST395 and ST15 (each
seven isolates, 10.5%; Potron et al., 2013). Two outbreaks of OXA-
48-producing K. pneumoniae ST101 clones were reported in
Spain (Pitart et al., 2011; Cubero et al., 2015). OXA-48-producing
K. pneumoniae appear to vary geographically. As with NDM, to
the best of our knowledge, ST258 harboring blaOXA−48−like has
never been reported.
Treatment Options
OXA-48-like-producing K. pneumoniae are usually resistant
to most β-lactam antibiotics, but OXA-48-producing
K. pneumoniae without ESBLs remain susceptible to the
expanded-spectrum cephalosporins (Nordmann et al., 2012a;
Munoz-Price et al., 2013). In addition, OXA-48-like-producing
Frontiers in Microbiology | www.frontiersin.org 15 June 2016 | Volume 7 | Article 895
fmicb-07-00895 June 9, 2016 Time: 14:36 # 16
Lee et al. Carbapenem-Resistant Klebsiella pneumoniae
K. pneumoniae sometimes remains susceptible to several
aminoglycosides such as gentamicin (Tzouvelekis et al., 2014).
Unlike for NDMs (Wiskirchen et al., 2013, 2014b; MacVane
et al., 2014), carbapenems may not be a reliable treatment
option for OXA-48 producer infection (Wiskirchen et al., 2014a).
Combination therapy with sulbactam, meropenem, and colistin
was more effective in isolates producing NDM carbapenemase
than those producing OXA-48-like carbapenemases, suggesting
that the identification of the carbapenemase type helps determine
the combination most likely to clear the infection (Laishram
et al., 2015). The combination of fosfomycin with imipenem,
meropenem, and tigecycline was also synergistic against OXA 48-
positive K. pneumoniae strains in vitro with the ratios of 42, 33,
and 33%, respectively (Evren et al., 2013). Similarly, the in vitro
assays indicate that imipenem-containing combinations were
effective against serine-β-lactamase producers (KPC, OXA-48),
while no synergy was observed for all NDM-1 producers (Poirel
et al., 2016). However, because carbapenems were effective
against NDM-1-producing isolates in vivo (Wiskirchen et al.,
2013, 2014a; MacVane et al., 2014), the effect of carbapenem
combination therapy on carbapenemase-producing isolates
should be determined in vivo, particularly in the case of
NDM-1-producing bacteria.
Despite the effectiveness of combination therapies, the
prognosis for bloodstream infections caused by OXA-48-
producing Enterobacteriaceae remains poor, and the 30-
days mortality reached 50% (Navarro-San Francisco et al.,
2013). A similar result was reported in OXA-48-producing
K. pneumoniae infections in a tertiary hospital in Spain (Pano-
Pardo et al., 2013). Although OXA-48-producing K. pneumoniae
were susceptible to several antibiotics, including amikacin (97.2%
susceptible), colistin (90.1%), tigecycline (73%), and fosfomycin
(66.2%), in-hospital mortality among patients with OXA-48-
producing K. pneumoniae infections was 43.5% (Pano-Pardo
et al., 2013). Therefore, to prevent delay in diagnosis and
initiation of optimal antimicrobial therapy, rapid identification
of OXA-48-producing isolates is required.
Detection Methods
As with KPCs and NDMs, various detection methods were
developed to identify OXA-48-like carbapenemases (Tsakris
et al., 2010; Giske et al., 2011; Girlich et al., 2013; Naas
et al., 2013; Lee et al., 2015c). Accurate differentiation of the
various carbapenemase types, such as KPC-type, NDM-type, and
OXA-48-type enzymes, is crucial for controlling the spread of
carbapenem resistance among Enterobacteriaceae (Nordmann
et al., 2012a). Many phenotypic detection methods to allow
differentiation between class A and class B carbapenemases
were developed using boronic acid derivatives and EDTA or
dipicolinic acid (Tsakris et al., 2010; Giske et al., 2011). Recently,
a specific phenotypic method to differentiate a single OXA-48
producer from those producing other carbapenemase types (e.g.,
KPC-types, NDM-types) was also developed (Tsakris et al., 2015).
This method was based on an imipenem disk and two blank disks
adjacent to the imipenem disk, loaded with the tested strain and
impregnated with EDTA and EDTA plus phenyl boronic acid,
respectively (Tsakris et al., 2015). This novel method exhibited
96.3% sensitivity and 97.7% specificity (Tsakris et al., 2015).
ChromID OXA-48, based on chromogenic media, have been
commercialized for the direct isolation of CPE from clinical
samples (Girlich et al., 2013), with an estimated 91% sensitivity
and 100% specificity (Girlich et al., 2013).
Emerging Class C Carbapenemases
Class C β-lactamases confer resistance to penicillins,
cephalosporins, and cephamycins (cefoxitin and cefotetan) and
are not significantly inhibited by clinically applied β-lactamase
inhibitors such as clavulanic acid (Jeon et al., 2015). Although
four class C carbapenemases (ACT-1, CMY-2, CMY-10, and
ADC-68) have been reported, ACT-1 and CMY-2 exhibit
reduced susceptibility to carbapenems, particularly ertapenem,
only when combined with permeability defects, due to their
low catalytic efficiencies (Kcat/Km) for imipenem (0.007 and
0.04 M−1·S−1, respectively; Mammeri et al., 2010). CMY-10
with the catalytic efficiency of 0.14 M−1·S−1 for imipenem
was the first reported carbapenemase among plasmidic class
C β-lactamases (Kim et al., 2006), and this enzyme was also a
class C extended-spectrum β-lactamase with extended substrate
specificity for extended-spectrum cephalosporins (Lee et al.,
2009, 2012a; Jeon et al., 2015). Among the chromosomal class C
β-lactamases, ADC-68 identified in A. baumannii was the first
reported enzyme possessing both class C extended-spectrum
β-lactamase and carbapenemase activities (Jeon et al., 2014,
2015), and its catalytic efficiency for imipenem is 0.17 M−1
S−1. CMY-10-producing K. pneumoniae was identified only in
South Korea (Lee et al., 2005a, 2006a) and ADC-68-producing
K. pneumoniae was never reported.
Many reports showed that carbapenem resistance can be
triggered by the loss of two major porins, OmpK35 and
OmpK36, in combination with ESBLs or Ambler class C AmpC
cephalosporinases, and the production of carbapenemase (Wang
et al., 2009; Shin et al., 2012; Tsai et al., 2013). A recently
genetically engineered mutant of K. pneumoniae showed that
several carbapenems (imipenem, meropenem, and doripenem)
remain effective against these carbapenemase-independent CR
strains (Tsai et al., 2013). Therefore, laboratory testing for
susceptibility to imipenem, meropenem, and doripenem can
improve the accuracy of identification of these isolates (Tsai et al.,
2013).
CONCLUSION
We analyzed the epidemiology of K. pneumoniae producing
true carbapenemases (Ambler molecular class A, B, D, and
several carbapenemases of class C) responsible for non-
susceptibility to carbapenems without additional permeability
defects. Many types of CR K. pneumoniae have been identified
worldwide (Figures 1, 3, and 4). During the past 3 years,
many countries have reported the arrival of carbapenemases
previously unreported in those countries. For example, although
K. pneumoniae producing KPC- and NDM-type carbapenemases
have been extensively reported in the USA, a K. pneumoniae
producing OXA-48-type carbapenemases was recently detected
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in the USA (Mathers et al., 2013). Since a first report
of NDM-1 in 2008, this carbapenemase has rapidly spread
worldwide, and NDM-producing K. pneumoniae still continues
to be found in new countries, implying that NDM-producing
K. pneumoniae is still spreading quickly. Despite the global
dissemination of KPC, NDM, and OXA-48, the prevalence of
carbapenemases varies geographically. The frequency of KPC-
and NDM-producing strains was significantly higher in the
USA, Canada, Greece, Taiwan, Colombia, and China, whereas
OXA-48-producing strains were rarely found in those countries
(Figures 1, 3, and 4). In Argentina, despite the extensive spread
of KPC- and OXA-48-producing strains, no NDM-producing
K. pneumoniae has been reported. Although NDM- and OXA-
48-producing K. pneumoniae significantly spread in Turkey,
KPC-producing strains have rarely been reported there. In Brazil,
KPC-producing K. pneumoniae has been mainly reported. In the
Arabian Peninsula, OXA-48 and NDM producers are common,
whereas KPC-type, VIM-type, or IMP-type producers are rare.
In India, Spain, France, Italy, and the UK, all three types of
carbapenemases have been frequently reported (Figures 1, 3,
and 4).
ST258 is an important strain responsible for the extensive
global spread of KPC-producing K. pneumoniae. Although the
precise reason for the predominance of the ST258 strain in
KPC-producing K. pneumoniae is not fully understood, recent
molecular studies unveiled the genetic characteristics of this
strain. The ST258 strains consists of two distinct genetic clades
(cps-1 and cps-2) derived from genetic differentiation in genes
involved in capsule polysaccharide biosynthesis. In addition,
the integrative conjugative element ICEKp258.2, present only in
ST258 and genetically related sequence types, may be linked to
the global success of the ST258 clone. ICEKp258.2 contains a
type IV pilus gene cluster and a type III restriction-modification
system. The type IV pilus gene cluster ICEKp258.2, particularly
pilV, may contribute to the global success of ST258 clone.
The type III restriction-modification system associated with
the restriction of plasmids and specific mobile elements may
explain the differences observed between ST258 predominantly
harboring KPC and ST11, another high-risk clone that lacks
ICEKp258.2, harboring various carbapenemases, such as NDM-
1, OXA-48, KPC-2, VIM-1, and OXA-245. IncF with FIIK
replicons, a plasmid most commonly identified in ST258 with
blaKPC, often contains several genes associated with resistance
to other antibiotics, such as aminoglycosides, tetracyclines,
quinolones, trimethoprim, and sulfonamides. The features of this
plasmid may also play an important role in the current global
success of ST258.
The rapid global spread of NDM-type carbapenemases may
be partly attributed to the dissemination of various epidemic
broad-host-range plasmids bearing the blaNDM genes. NDM-
type carbapenemases were found in various plasmids such
as IncA/C, IncF, IncR, IncH, IncN, IncL/M, and IncX types.
The IncA/C type plasmids, most common plasmids associated
with spread of the blaNDM genes, often have various antibiotic
resistance genes, such as 16S rRNA methylases associated with
aminoglycoside resistance, CMY-type β-lactamases associated
with broad-spectrum cephalosporin resistance, and QnrA
associated with quinolone resistance. These features may
be linked to the current global success of NDM-producing
K. pneumoniae.
The current spread of OXA-48-producing bacteria is
attributed to the pOX-48a plasmid, which belongs to the IncL
group of IncL/M type plasmids. Although the pOXA-48a
plasmid contains blaOXA−48, a unique antibiotic resistance gene,
the conjugation rate of the pOXA-48a plasmid was very high,
which may be responsible for its global spread in K. pneumoniae.
The high pOXA-48a conjugation rate was recently attributed to
mutations in the tir gene known to encode a transfer inhibition
protein, which may lead to a 50- to 100-fold increase in the
efficiency of transfer of the pOXA-48a plasmid. Furthermore,
the pOXA-48a plasmid is self-conjugative. Therefore, these
specific features of the pOXA-48a plasmid may explain the global
dissemination of OXA-48-type carbapenemases.
ST11, ST14, ST101, ST147, and ST258 are major
carbapenemase-producing K. pneumoniae clones. ST258
was mainly found in KPC-producing K. pneumoniae, whereas
other clones were found in various carbapenemase-producing
K. pneumoniae regardless of carbapenemase types. Well-
designed epidemiological and molecular studies will be required
to understand the dynamics of transmission, risk factors, and
reservoirs of these K. pneumoniae clones. This will provide
information essential for preventing infections and the spread of
these risky sequence types.
Most currently available antibiotics may be not sufficiently
effective for the treatment of all types of carbapenemase
producers in monotherapy. Combination therapy of
carbapenems with polymyxin B, colistin, rifampin, fosfomycin, or
tigecycline has been reported to effectively treat carbapenemase-
producing K. pneumoniae. Despite these data supporting
the use of combination therapy for treatment of severe
carbapenemase-producing K. pneumoniae infections, current
clinical evidence for treatment guidelines are limited and more
accurate randomized controlled in vivo studies are required.
Moreover, considerable caution is required when applying these
therapies. For example, temocillin can actively treat against
some KPC-producing K. pneumoniae, particularly lower urinary
tract infections, and NDM-producing K. pneumoniae is often
susceptible to aztreonam. OXA-48-producing K. pneumoniae
remain susceptible to the expanded-spectrum cephalosporins
in approximately 20% of cases without ESBLs. In the case of
NDM-1-producing K. pneumoniae, carbapenems were recently
reported to represent a viable treatment option for infections
caused by these bacteria, despite unfavorable in vitro MICs.
Because these results imply that carbapenems can sometimes
be a viable treatment option for infection with carbapenemase
producers, more extensive studies on the effect of carbapenem
monotherapy will be required in the case of NDM-producing
K. pneumoniae infections.
The accurate and rapid detection of the genotype of
carbapenemases can minimize the delay to appropriate
prescription of antibiotics. Many detection kits based on
various phenotypic or molecular techniques, such as multiplex
PCR assay, real-time PCR assay, DNA microarray, Raman
spectroscopic analysis, single-colony whole-genome sequencing,
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MALDI-TOF MS, loop-mediated isothermal amplification
method, chromogenic medium, and new phenotypic test
methods, have been developed. Through the imprudent use
of colistin which is a key component used for the treatment
of severe carbapenemase-producing K. pneumoniae infections,
the rapid spread of colistin resistance was recently reported in
K. pneumoniae producing carbapenemases, particularly KPC-
type carbapenemases. This situation strongly demonstrates the
need for the development of novel accurate and reliable methods
for detecting resistance to clinically important antimicrobial
agents, such as colistin. Hospital interventions can effectively
reduce the spread of carbapenemase-producing K. pneumoniae.
Standard infection control guidelines should be implemented
upon the detection of carbapenemase-producing K. pneumoniae,
and carbapenemase-producing K. pneumoniae positive patients
should be individually isolated and treated according to strict
standard guidelines.
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